share_log

Opinion: The 6 best penny stocks to buy for September

Opinion: The 6 best penny stocks to buy for September

點評:9月份最值得買入的6只便宜股
InvestorPlace ·  2021/08/30 11:56  · 觀點

There is no question that the pandemic has brought a significant increase in day traders. And for many of these traders, penny stocks are a convenient investment of choice.

毫無疑問,大流行帶來了日內交易者的大幅增加。對於這些交易員中的許多人來説,細價股是一種方便的投資選擇。

There’s no “right” definition for what constitutes a penny stock. Some investors will say the stock must be trading below $1. Others may put the threshold at $5; some may go as high as $10. The general point is that penny stocks are inexpensive to buy.

對於什麼是細價股,沒有“正確”的定義。一些投資者會説,股票的交易價格一定在1美元以下。另一些人可能會把門檻定在5美元,有些人可能會高達10美元。大體上來説,購買細價股並不貴。

But along with that low price comes a significant risk. After all, many penny stocks are trading at a low price for a reason. And one reason could be that the company is under significant financial duress.

但伴隨着低價而來的是一個巨大的風險。畢竟,許多低價股的交易價格較低是有原因的。其中一個原因可能是該公司面臨巨大的財務壓力。

However, if an investor is willing to accept that risk and do a little research, investing in penny stocks can be an intriguing numbers game. After all, with so many to choose from, a handful will undoubtedly turn out to be winners. And when you factor in that many of today’s retail investors aren’t buy-and-hold investors, there’s even more incentive to take a risk on a few penny stocks.

然而,如果投資者願意接受這種風險並做一些研究,投資細價股可能是一場有趣的數字遊戲。畢竟,有這麼多人可供選擇,少數人無疑會成為贏家。如果你考慮到今天的許多散户投資者不是買入並持有的投資者,你就會更有動力去冒險購買幾隻便士股票。

And as the calendar turns to September, it’s a good time to take a look at six penny stocks that look like good buys.

隨着日曆轉到9月份,現在是看一看看起來很划算的6只便宜股的好時機。

Penny Stocks: Romeo Power (RMO)

低價股:羅密歐電力公司(Romeo Power)

Romeo Power is a good example of the volatility that can be found in the price of penny stocks. One month ago, RMO stock closed at $7.05. But in that span, the stock fell to a closing low of $4.20. And as of this writing, the stock is trading at $5.02.

羅密歐電力公司(Romeo Power)就是一個很好的例子,説明了細價股價格的波動性。一個月前,RMO的股票收盤價為7.05美元。但在此期間,該股跌至4.20美元的收盤低點。在撰寫本文時,該股的交易價格為5.02美元。

As for the company itself, Romeo Power is engaged in manufacturing of lithium-ion batteries for Class 1 to Class 8 commercial trucks. The company’s innovative design features “up to 30%” greater energy density than current lithium-ion batteries. For fleet operators, this means batteries would hold a charge longer and need to be recharged less frequently.

至於公司本身,羅密歐電力公司(Romeo Power)從事1至8級商用卡車用鋰離子電池的製造。該公司的創新設計比目前的鋰離子電池的能量密度高出“30%”。對於車隊運營商來説,這意味着電池充電的時間更長,需要充電的頻率更低。

Another benefit, according to the company, is that the battery will hold optimal temperature even in the parts of the country that are subject to extreme heat or cold.

據該公司稱,另一個好處是,即使在美國極端炎熱或寒冷的地區,電池也能保持最佳温度。

There is a lot of competition in this space, including from companies such as Hyliion (NYSE:HYLN) which are offering Class 8 trucks with their own innovative solutions. However, with solid-state batteries likely still a few years away, Romeo Power may have an opportunity to wedge itself into the conversation.

在這個領域有很多競爭,包括來自以下公司的競爭海利安紐約證券交易所代碼:HYLN),它們提供具有自己的創新解決方案的8類卡車。然而,由於固態電池可能還需要幾年時間,羅密歐電力公司(Romeo Power)可能有機會加入到這一對話中來。

Of the five analysts that have rated RMO stock, the consensus price target is $8.14 which would be a gain of over 60% from current levels.

在對RMO股票進行評級的五位分析師中,一致認為目標價為8.14美元,比目前水平上漲了60%以上。

Meta Materials (MMAT)

元材料(MMAT)

Many of the penny stocks on this list have been caught up in the meme stock movement at one time or another this year. And MMAT stock is no exception. At the end of June, the stock closed at $7.49 — a level investors had not seen for seven years. And with the price back down to $5.20 as of this writing, it’s fair to say that many traders took their profits and went looking for another target.

這份榜單上的許多細價股都在今年的某個時候捲入了表情包股票運動。MMAT股票也不例外。6月底,該股收於7.49美元,這是投資者七年來未曾見過的水平。在撰寫本文時,隨着金價回落至5.20美元,可以公平地説,許多交易員獲利回吐,轉而尋找另一個目標。

Meta Materials manufactures and develops “functional materials” and is known for being on the cutting edge of technological breakthroughs in this area. Essentially the company is looking to develop intellectual property that it can sell to the right partners.

Meta Materials製造和開發“功能材料”,並以處於該領域技術突破的前沿而聞名。從本質上説,該公司正在尋求開發知識產權,以便出售給合適的合作伙伴。

The company recently formed a scientific advisory board which is likely to allow the company to develop stronger, more diverse products.

該公司最近成立了一家科學顧問委員會這可能會讓該公司開發出更強大、更多樣化的產品。

This is far from a sure thing. But for investors looking for a penny stock that could have some growth for the remainder of 2021, I’d encourage you to keep Meta Materials on your watch list. If it breaks past a point of resistance, there could be some short-term upside.

這遠非板上釘釘的事。但對於尋找在2021年剩餘時間內可能有一些增長的細價股的投資者來説,我建議你將Meta Material留在你的觀察名單上。如果突破阻力位,短期內可能會有一些上行空間。

Penny Stocks: Biolase (BIOL)

細價股:Biolase(Biol)

One way to evaluate the value of a penny stock investment is to look at its potential market. And that’s why Biolase is a penny stock that merits consideration.

評估細價股投資價值的一種方法是看它的潛在市場。這就是為什麼Biolase是一隻值得考慮的便士股票。

The company produces medical devices for the dental industry. This was a sector that was devastated as many dentist’s offices closed for obvious reasons.

該公司為牙科行業生產醫療器械。這是一個被摧毀的領域,因為許多牙醫的診所因為顯而易見的原因而關閉。

But with the economy restarting, Biolase looks like a strong reopening stock. Investors seem to agree. After being part of the meme stock movement in January and February, BIOL stock has charged ahead more than 30% in the past month.

但隨着經濟重啟,Biolase看起來像是一隻強勁的重新開盤股票。投資者似乎對此表示同意。在1月和2月成為表情包股票運動的一部分後,Biol股票在過去一個月裏上漲了30%以上。

Biolase holds over 270 patents with 40 other technologies patent-pending as of this writing. And the company has sold its products in 80 countries. Analyst sentiment looks positive, with an average price target of $2.25. One reason for that may have been the company’s appointment of three new board members who have significant experience in the dental industry.

截至撰寫本文時,Biolase擁有270多項專利,還有40項其他技術正在申請專利。該公司已在80個國家銷售其產品。分析師的情緒看起來很積極,平均目標價為2.25美元。其中一個原因可能是該公司任命了三名在牙科行業擁有豐富經驗的新董事會成員。

MannKind Corp (MNKD)

曼肯德公司(MannKind Corp)

You’ll find a lot of biopharmaceutical companies like MannKind among lists of penny stocks. One reason for this is that these companies frequently are in the “pre-revenue” stage (i.e. they don’t have a product that’s in market yet).

在廉價股名單中,你會發現很多像曼肯德這樣的生物製藥公司。其中一個原因是這些公司經常處於“預收”階段(即他們還沒有產品上市)。

That’s not the case for MannKind, which has managed to get a product approved and is in use. The main product — Afrezza — is a prescription glucose management product that is inhaled as a powder. The therapeutic is approved for adult use. MannKind is also peripherally involved in developing a therapeutic, which may explain some of its volatility. However, because it has Afrezza, investors don’t have to rely on that product panning out.

但MannKind的情況並非如此,它已經設法讓一款產品獲得批准並投入使用。主要產品Afrezza是一種處方藥葡萄糖管理產品,可作為粉末吸入。這種療法被批准成人使用。MannKind還在外圍參與了一種治療藥物的開發,這可能可以解釋它的一些波動性。然而,因為它擁有Afrezza,投資者不必依賴該產品的成功。

That being said, MNKD stock has closed over $6 a share this year and it’s traded under $5.

話雖如此,MNKD股票今年的收盤價已超過每股6美元,目前交易價格低於5美元。

The consensus opinion among six analysts gives the stock a 25% upside from its current level.

六位分析師的一致意見認為,該股較當前水平上漲25%。

Penny Stocks: DatChat Inc. (DATS)

細價股:DatChat Inc.(DATS)

If you’re a risk-tolerant investor, it can be exciting to get in on the ground floor of a newly public company. And that’s your opportunity with DatChat. The company just began publicly trading shares on Aug. 13, 2021.

如果你是一位風險承受力強的投資者,進入一家新上市公司的底層可能會令人興奮。這就是你使用DatChat的機會。該公司剛剛於2021年8月13日開始公開交易股票。

And you can say it’s been a success. DATS stock has nearly doubled in the two weeks that it has been trading. It’s already well over $7, straining all but the most lenient of penny stock definitions.

你可以説這是一次成功。DATS的股票在其交易的兩週內幾乎翻了一番。它已經遠遠超過了7美元,除了最寬鬆的細價股定義之外,所有的定義都變得緊張起來。

Of course, it could also crash. That’s the risk with penny stocks. But let’s keep our eyes on the bullish side of this stock. DatChat is a technology company that creates communication software for, among other things, mobile messaging applications. The company’s signature product, DatChat Messenger emphasizes privacy and protection. Plus, the company is developing a blockchain-based communications platform which is adding to the buzz around the company.

當然,它也可能崩潰。這就是細價股的風險所在。但讓我們關注這隻股票看漲的一面。DatChat是一家技術公司,專門為移動通訊應用程序等開發通信軟件。該公司的標誌性產品DatChat Messenger強調隱私和保護。此外,該公司正在開發一個基於區塊鏈的通信平台,這增加了圍繞該公司的熱議。

The combination of a tech startup and the blockchain will likely make DATS stock irresistible to day traders. And that means it may be a short squeeze candidate eventually. However, it’s definitely a stock that should be on your watch list.

一家科技初創公司與區塊鏈的結合可能會讓DATS股票對日內交易者具有不可抗拒的吸引力。這意味着它最終可能是一個短期擠壓的候選人。然而,它絕對是一隻應該出現在你的觀察名單上的股票。

Inuvo (INUV)

因紐沃(Inuvo)

The last of the penny stocks to consider is a true penny stock. That is, INUV stock is trading for less than $1 per share as of this writing. Inuvo provides targeted media and display advertising solutions for eCommerce companies. That puts the company firmly in the vanguard of the explosive growth in e-commerce in the last year.

最後一個要考慮的細價股是真正的細價股。也就是説,在撰寫本文時,INUV的股票交易價格不到每股1美元。因紐沃為電子商務公司提供有針對性的媒體和展示廣告解決方案。這使該公司牢牢地站在了去年電子商務爆炸性增長的先鋒地位。

At one point this year, INUV stock was trading for over $2. But it’s now hovering around 72 cents a share. That’s still about a 60% gain for investors who bought shares at the beginning of the year. However, it also illustrates the risk and the reward that can come with investing in penny stocks.

今年,INUV的股價一度超過2美元,但現在徘徊在每股72美分左右。對於年初買入股票的投資者來説,這仍是60%左右的收益。然而,它也説明了投資細價股可能帶來的風險和回報。

The company is not yet profitable. However, it beat analysts’ expectations for revenue. In its most recent quarter, revenue came in 66% higher on a year-over-year basis.

該公司尚未實現盈利。然而,它超出了分析師對收入的預期。在最近一個季度,該公司營收同比增長66%。

And the company offered guidance that suggests double-digit revenue gains are likely to continue. And as they do, Inuvo expects that it will begin to post positive EBITDA.

該公司提供的指引表明,兩位數的收入增長可能會持續下去。隨着他們這樣做,因紐沃預計它將開始公佈正的EBITDA。

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks. 

關於細價股和低成交量股票: 除了極少數例外,不會發布關於市值低於1億美元或每天交易量低於100,000股的公司的評論。這是因為這些“廉價股”經常是詐騙藝術家和市場操縱者的遊樂場。如果我們對可能受我們的評論影響的低成交量股票發表評論,我們要求InvestorPlace.com該書的作者披露了這一事實,並警告讀者其中的風險。

On the date of publication, Chris Markoch did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

在出版之日,克里斯·馬科赫(Chris Markoch)沒有(直接或間接)持有本文所述證券的任何頭寸。本文表達的觀點是作者的觀點,以InvestorPlace.com為準出版指南.

Chris Markoch is a freelance financial copywriter who has been covering the market for seven years. He has been writing for InvestorPlace since 2019.

克里斯·馬科赫(Chris Markoch)是一名自由財經文案,已經報道該市場七年了。自2019年以來,他一直在為InvestorPlace寫作。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論